Form 4 · Filed Jul 22, 2026, 09:03 PM UTC
ONC/BeOne Medicines Ltd.
OYLER JOHN — Chief Executive Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
16 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jul 21, 2026 | S | sell | 20,029 | $317 | $6,347,340 | 25,989 |
| Jul 21, 2026 | S | sell | 7,842 | $318 | $2,496,997 | 18,147 |
| Jul 21, 2026 | S | sell | 15,807 | $319 | $5,047,019 | 2,340 |
| Jul 21, 2026 | S | sell | 2,340 | $320 | $748,936 | 0 |
| Jul 21, 2026 | S | sell | 15,379 | $316 | $4,863,766 | 46,018 |
| Jul 20, 2026 | S | sell | 14,326 | $313 | $4,483,433 | 4,165 |
| Jul 20, 2026 | S | sell | 1,850 | $314 | $580,732 | 2,315 |
| Jul 20, 2026 | S | sell | 1,512 | $315 | $476,678 | 803 |
| Jul 20, 2026 | S | sell | 523 | $316 | $165,339 | 280 |
| Jul 20, 2026 | S | sell | 280 | $318 | $89,124 | 0 |
| Jul 20, 2026 | S | sell | 5,146 | $310 | $1,595,678 | 9,180 |
| Jul 20, 2026 | M | other | 441,870 | — | — | 0 |
| Jul 20, 2026 | S | sell | 6,273 | $311 | $1,949,310 | 2,907 |
| Jul 20, 2026 | S | sell | 2,907 | $312 | $906,389 | 0 |
| Jul 20, 2026 | M | other | 33,990 | $120 | $4,077,440 | 33,990 |
| Jul 20, 2026 | S | sell | 15,499 | $312 | $4,840,115 | 18,491 |
Source: SEC EDGAR raw filing ↗ · Accession 0001042047-26-000017